Literature DB >> 9868748

Short form 36 (SF-36) health survey: normative data from the general Norwegian population.

J H Loge1, S Kaasa.   

Abstract

Anchoring health-related quality of life (HRQOL) measures in population norms makes clinical interpretations more meaningful and is in accordance with practice in other fields of medicine. In this paper norms for the Short Form 36 (SF-36) are presented in a random sample, representative of the general Norwegian population. In addition, sociodemographic variables affecting the scale scores are explored and discussed. The response rate was 67%, being lowest among subjects aged 70 years or over. Data-completeness strongly declined with increasing age. Physical health scales were also strongly affected by age. In all scales, with the exception of general health perceptions, women reported having poorer health than men. Marital status affected the four mental health scales. Educational status affected all the scales, but the effect was smallest in the mental scales. These norms can be employed for comparison in case-control studies, or to interpret HRQOL changes in prospective studies. Differences in social status should be given special attention. Caution should be exercised when assessing subjective health or employing the norms among subjects aged 70 years or over.

Entities:  

Mesh:

Year:  1998        PMID: 9868748

Source DB:  PubMed          Journal:  Scand J Soc Med        ISSN: 0300-8037


  144 in total

1.  SF-36 normative values according to level of functioning in older women.

Authors:  Geeske Peeters; Michael Waller; Annette J Dobson
Journal:  Qual Life Res       Date:  2018-12-03       Impact factor: 4.147

2.  Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS).

Authors:  Lars-Petter Jelsness-Jørgensen; Tomm Bernklev; Bjørn Moum
Journal:  Qual Life Res       Date:  2011-12-07       Impact factor: 4.147

3.  Validity of standard gamble utilities in patients referred for aortic valve replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Jan Otto Beitnes; Lars Gullestad; Kjell I Pettersen
Journal:  Qual Life Res       Date:  2015-11-24       Impact factor: 4.147

4.  Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS.

Authors:  Knut Stavem; Stig S Frøland; Kjell B Hellum
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

5.  Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.

Authors:  Maria Bjerk; Therese Brovold; Jennifer C Davis; Astrid Bergland
Journal:  Qual Life Res       Date:  2019-07-30       Impact factor: 4.147

6.  Changes in Health-Related Quality of Life After Gastric Bypass in Patients With and Without Obesity-Related Disease.

Authors:  Hilde Risstad; Torgeir T Søvik; Stephen Hewitt; Jon A Kristinsson; Morten W Fagerland; Tomm Bernklev; Tom Mala
Journal:  Obes Surg       Date:  2015-12       Impact factor: 4.129

7.  Follow-up after intensive care: a single center study.

Authors:  Reidar Kvåle; Atle Ulvik; Hans Flaatten
Journal:  Intensive Care Med       Date:  2003-11-04       Impact factor: 17.440

8.  Reliability and validity of the Norwegian version of the Functional Outcomes of Sleep Questionnaire.

Authors:  Knut Stavem; Frank N Kjelsberg; Espen A Ruud
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

9.  Is health-related quality of life associated with the risk of low-energy wrist fracture: a case-control study.

Authors:  Gudrun Rohde; Anne M Mengshoel; Astrid K Wahl; Torbjorn Moum; Glenn Haugeberg
Journal:  BMC Musculoskelet Disord       Date:  2009-07-03       Impact factor: 2.362

10.  No long-term impact of low-energy distal radius fracture on health-related quality of life and global quality of life: a case-control study.

Authors:  Gudrun Rohde; Glenn Haugeberg; Anne Marit Mengshoel; Torbjorn Moum; Astrid K Wahl
Journal:  BMC Musculoskelet Disord       Date:  2009-08-25       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.